Global Competent Cells Market Size, Status and Forecast 2023

Report ID: 1234530 | Published Date: Sep 2024 | No. of Page: 128 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chemically Competent Cells
        1.2.3 Electrocompetent Cells
    1.3 Market by Application
        1.3.1 Global Competent Cells Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Subcloning & Routine Cloning
        1.3.3 Phage Display Library Construction
        1.3.4 Toxic/Unstable DNA Cloning
        1.3.5 High-Throughput Cloning
        1.3.6 Protein Expression
        1.3.7 Mutagenesis
        1.3.8 Single-Stranded DNA Production
        1.3.9 Bacmid Creation
        1.3.10 Cre-Lox Recombination (PIR1/PIR2)
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Competent Cells Market Perspective (2016-2027)
    2.2 Competent Cells Growth Trends by Regions
        2.2.1 Competent Cells Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Competent Cells Historic Market Share by Regions (2016-2021)
        2.2.3 Competent Cells Forecasted Market Size by Regions (2022-2027)
    2.3 Competent Cells Industry Dynamic
        2.3.1 Competent Cells Market Trends
        2.3.2 Competent Cells Market Drivers
        2.3.3 Competent Cells Market Challenges
        2.3.4 Competent Cells Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Competent Cells Players by Revenue
        3.1.1 Global Top Competent Cells Players by Revenue (2016-2021)
        3.1.2 Global Competent Cells Revenue Market Share by Players (2016-2021)
    3.2 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Competent Cells Revenue
    3.4 Global Competent Cells Market Concentration Ratio
        3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2020
    3.5 Competent Cells Key Players Head office and Area Served
    3.6 Key Players Competent Cells Product Solution and Service
    3.7 Date of Enter into Competent Cells Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Competent Cells Breakdown Data by Type
    4.1 Global Competent Cells Historic Market Size by Type (2016-2021)
    4.2 Global Competent Cells Forecasted Market Size by Type (2022-2027)

5 Competent Cells Breakdown Data by Application
    5.1 Global Competent Cells Historic Market Size by Application (2016-2021)
    5.2 Global Competent Cells Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Competent Cells Market Size (2016-2027)
    6.2 North America Competent Cells Market Size by Type
        6.2.1 North America Competent Cells Market Size by Type (2016-2021)
        6.2.2 North America Competent Cells Market Size by Type (2022-2027)
        6.2.3 North America Competent Cells Market Size by Type (2016-2027)
    6.3 North America Competent Cells Market Size by Application
        6.3.1 North America Competent Cells Market Size by Application (2016-2021)
        6.3.2 North America Competent Cells Market Size by Application (2022-2027)
        6.3.3 North America Competent Cells Market Size by Application (2016-2027)
    6.4 North America Competent Cells Market Size by Country
        6.4.1 North America Competent Cells Market Size by Country (2016-2021)
        6.4.2 North America Competent Cells Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Competent Cells Market Size (2016-2027)
    7.2 Europe Competent Cells Market Size by Type
        7.2.1 Europe Competent Cells Market Size by Type (2016-2021)
        7.2.2 Europe Competent Cells Market Size by Type (2022-2027)
        7.2.3 Europe Competent Cells Market Size by Type (2016-2027)
    7.3 Europe Competent Cells Market Size by Application
        7.3.1 Europe Competent Cells Market Size by Application (2016-2021)
        7.3.2 Europe Competent Cells Market Size by Application (2022-2027)
        7.3.3 Europe Competent Cells Market Size by Application (2016-2027)
    7.4 Europe Competent Cells Market Size by Country
        7.4.1 Europe Competent Cells Market Size by Country (2016-2021)
        7.4.2 Europe Competent Cells Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Competent Cells Market Size (2016-2027)
    8.2 Asia-Pacific Competent Cells Market Size by Type
        8.2.1 Asia-Pacific Competent Cells Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Competent Cells Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Competent Cells Market Size by Type (2016-2027)
    8.3 Asia-Pacific Competent Cells Market Size by Application
        8.3.1 Asia-Pacific Competent Cells Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Competent Cells Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Competent Cells Market Size by Application (2016-2027)
    8.4 Asia-Pacific Competent Cells Market Size by Region
        8.4.1 Asia-Pacific Competent Cells Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Competent Cells Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Competent Cells Market Size (2016-2027)
    9.2 Latin America Competent Cells Market Size by Type
        9.2.1 Latin America Competent Cells Market Size by Type (2016-2021)
        9.2.2 Latin America Competent Cells Market Size by Type (2022-2027)
        9.2.3 Latin America Competent Cells Market Size by Type (2016-2027)
    9.3 Latin America Competent Cells Market Size by Application
        9.3.1 Latin America Competent Cells Market Size by Application (2016-2021)
        9.3.2 Latin America Competent Cells Market Size by Application (2022-2027)
        9.3.3 Latin America Competent Cells Market Size by Application (2016-2027)
    9.4 Latin America Competent Cells Market Size by Country
        9.4.1 Latin America Competent Cells Market Size by Country (2016-2021)
        9.4.2 Latin America Competent Cells Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Competent Cells Market Size (2016-2027)
    10.2 Middle East & Africa Competent Cells Market Size by Type
        10.2.1 Middle East & Africa Competent Cells Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Competent Cells Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Competent Cells Market Size by Type (2016-2027)
    10.3 Middle East & Africa Competent Cells Market Size by Application
        10.3.1 Middle East & Africa Competent Cells Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Competent Cells Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Competent Cells Market Size by Application (2016-2027)
    10.4 Middle East & Africa Competent Cells Market Size by Country
        10.4.1 Middle East & Africa Competent Cells Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Competent Cells Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Merck KGaA
        11.1.1 Merck KGaA Company Details
        11.1.2 Merck KGaA Business Overview
        11.1.3 Merck KGaA Competent Cells Introduction
        11.1.4 Merck KGaA Revenue in Competent Cells Business (2016-2021)
        11.1.5 Merck KGaA Recent Development
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Details
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific Competent Cells Introduction
        11.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2016-2021)
        11.2.5 Thermo Fisher Scientific Recent Development
    11.3 Agilent Technologies
        11.3.1 Agilent Technologies Company Details
        11.3.2 Agilent Technologies Business Overview
        11.3.3 Agilent Technologies Competent Cells Introduction
        11.3.4 Agilent Technologies Revenue in Competent Cells Business (2016-2021)
        11.3.5 Agilent Technologies Recent Development
    11.4 Takara Bio
        11.4.1 Takara Bio Company Details
        11.4.2 Takara Bio Business Overview
        11.4.3 Takara Bio Competent Cells Introduction
        11.4.4 Takara Bio Revenue in Competent Cells Business (2016-2021)
        11.4.5 Takara Bio Recent Development
    11.5 Promega Corporation
        11.5.1 Promega Corporation Company Details
        11.5.2 Promega Corporation Business Overview
        11.5.3 Promega Corporation Competent Cells Introduction
        11.5.4 Promega Corporation Revenue in Competent Cells Business (2016-2021)
        11.5.5 Promega Corporation Recent Development
    11.6 Beijing TransGen Biotech
        11.6.1 Beijing TransGen Biotech Company Details
        11.6.2 Beijing TransGen Biotech Business Overview
        11.6.3 Beijing TransGen Biotech Competent Cells Introduction
        11.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2016-2021)
        11.6.5 Beijing TransGen Biotech Recent Development
    11.7 GeneScript Corporation
        11.7.1 GeneScript Corporation Company Details
        11.7.2 GeneScript Corporation Business Overview
        11.7.3 GeneScript Corporation Competent Cells Introduction
        11.7.4 GeneScript Corporation Revenue in Competent Cells Business (2016-2021)
        11.7.5 GeneScript Corporation Recent Development
    11.8 Yeastern Biotech
        11.8.1 Yeastern Biotech Company Details
        11.8.2 Yeastern Biotech Business Overview
        11.8.3 Yeastern Biotech Competent Cells Introduction
        11.8.4 Yeastern Biotech Revenue in Competent Cells Business (2016-2021)
        11.8.5 Yeastern Biotech Recent Development
    11.9 New England Biolabs
        11.9.1 New England Biolabs Company Details
        11.9.2 New England Biolabs Business Overview
        11.9.3 New England Biolabs Competent Cells Introduction
        11.9.4 New England Biolabs Revenue in Competent Cells Business (2016-2021)
        11.9.5 New England Biolabs Recent Development
    11.10 QIAGEN N.V.
        11.10.1 QIAGEN N.V. Company Details
        11.10.2 QIAGEN N.V. Business Overview
        11.10.3 QIAGEN N.V. Competent Cells Introduction
        11.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2016-2021)
        11.10.5 QIAGEN N.V. Recent Development
    11.11 OriGene Technologies
        11.11.1 OriGene Technologies Company Details
        11.11.2 OriGene Technologies Business Overview
        11.11.3 OriGene Technologies Competent Cells Introduction
        11.11.4 OriGene Technologies Revenue in Competent Cells Business (2016-2021)
        11.11.5 OriGene Technologies Recent Development
    11.12 Lucigen
        11.12.1 Lucigen Company Details
        11.12.2 Lucigen Business Overview
        11.12.3 Lucigen Competent Cells Introduction
        11.12.4 Lucigen Revenue in Competent Cells Business (2016-2021)
        11.12.5 Lucigen Recent Development
    11.13 Zymo Research
        11.13.1 Zymo Research Company Details
        11.13.2 Zymo Research Business Overview
        11.13.3 Zymo Research Competent Cells Introduction
        11.13.4 Zymo Research Revenue in Competent Cells Business (2016-2021)
        11.13.5 Zymo Research Recent Development
    11.14 Bio-Rad Laboratories
        11.14.1 Bio-Rad Laboratories Company Details
        11.14.2 Bio-Rad Laboratories Business Overview
        11.14.3 Bio-Rad Laboratories Competent Cells Introduction
        11.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2016-2021)
        11.14.5 Bio-Rad Laboratories Recent Development
    11.15 Bioline
        11.15.1 Bioline Company Details
        11.15.2 Bioline Business Overview
        11.15.3 Bioline Competent Cells Introduction
        11.15.4 Bioline Revenue in Competent Cells Business (2016-2021)
        11.15.5 Bioline Recent Development
    11.16 Delphi Genetics
        11.16.1 Delphi Genetics Company Details
        11.16.2 Delphi Genetics Business Overview
        11.16.3 Delphi Genetics Competent Cells Introduction
        11.16.4 Delphi Genetics Revenue in Competent Cells Business (2016-2021)
        11.16.5 Delphi Genetics Recent Development
    11.17 IBA GmBH
        11.17.1 IBA GmBH Company Details
        11.17.2 IBA GmBH Business Overview
        11.17.3 IBA GmBH Competent Cells Introduction
        11.17.4 IBA GmBH Revenue in Competent Cells Business (2016-2021)
        11.17.5 IBA GmBH Recent Development
    11.18 Cell Applications
        11.18.1 Cell Applications Company Details
        11.18.2 Cell Applications Business Overview
        11.18.3 Cell Applications Competent Cells Introduction
        11.18.4 Cell Applications Revenue in Competent Cells Business (2016-2021)
        11.18.5 Cell Applications Recent Development
    11.19 BioDynamics Laboratory
        11.19.1 BioDynamics Laboratory Company Details
        11.19.2 BioDynamics Laboratory Business Overview
        11.19.3 BioDynamics Laboratory Competent Cells Introduction
        11.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2016-2021)
        11.19.5 BioDynamics Laboratory Recent Development
    11.20 Scarab Genomics
        11.20.1 Scarab Genomics Company Details
        11.20.2 Scarab Genomics Business Overview
        11.20.3 Scarab Genomics Competent Cells Introduction
        11.20.4 Scarab Genomics Revenue in Competent Cells Business (2016-2021)
        11.20.5 Scarab Genomics Recent Development
    11.21 GCC Biotech
        11.21.1 GCC Biotech Company Details
        11.21.2 GCC Biotech Business Overview
        11.21.3 GCC Biotech Competent Cells Introduction
        11.21.4 GCC Biotech Revenue in Competent Cells Business (2016-2021)
        11.21.5 GCC Biotech Recent Development
    11.22 SMOBIO Technology
        11.22.1 SMOBIO Technology Company Details
        11.22.2 SMOBIO Technology Business Overview
        11.22.3 SMOBIO Technology Competent Cells Introduction
        11.22.4 SMOBIO Technology Revenue in Competent Cells Business (2016-2021)
        11.22.5 SMOBIO Technology Recent Development
    11.23 Edge BioSystems
        11.23.1 Edge BioSystems Company Details
        11.23.2 Edge BioSystems Business Overview
        11.23.3 Edge BioSystems Competent Cells Introduction
        11.23.4 Edge BioSystems Revenue in Competent Cells Business (2016-2021)
        11.23.5 Edge BioSystems Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemically Competent Cells
    Table 3. Key Players of Electrocompetent Cells
    Table 4. Global Competent Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Competent Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Competent Cells Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Competent Cells Market Share by Regions (2016-2021)
    Table 8. Global Competent Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Competent Cells Market Share by Regions (2022-2027)
    Table 10. Competent Cells Market Trends
    Table 11. Competent Cells Market Drivers
    Table 12. Competent Cells Market Challenges
    Table 13. Competent Cells Market Restraints
    Table 14. Global Competent Cells Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Competent Cells Market Share by Players (2016-2021)
    Table 16. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2020)
    Table 17. Ranking of Global Top Competent Cells Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Competent Cells Product Solution and Service
    Table 21. Date of Enter into Competent Cells Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Competent Cells Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Competent Cells Revenue Market Share by Type (2016-2021)
    Table 25. Global Competent Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Competent Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Competent Cells Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Competent Cells Revenue Market Share by Application (2016-2021)
    Table 29. Global Competent Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Competent Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Competent Cells Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Competent Cells Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Competent Cells Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Competent Cells Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Competent Cells Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Competent Cells Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Competent Cells Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Competent Cells Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Competent Cells Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Competent Cells Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Competent Cells Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Competent Cells Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Competent Cells Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Competent Cells Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Competent Cells Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Competent Cells Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Competent Cells Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Competent Cells Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Competent Cells Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Competent Cells Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Competent Cells Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Competent Cells Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Competent Cells Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Competent Cells Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Competent Cells Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Competent Cells Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Competent Cells Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Competent Cells Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Competent Cells Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Competent Cells Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Merck KGaA Company Details
    Table 62. Merck KGaA Business Overview
    Table 63. Merck KGaA Competent Cells Product
    Table 64. Merck KGaA Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 65. Merck KGaA Recent Development
    Table 66. Thermo Fisher Scientific Company Details
    Table 67. Thermo Fisher Scientific Business Overview
    Table 68. Thermo Fisher Scientific Competent Cells Product
    Table 69. Thermo Fisher Scientific Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 70. Thermo Fisher Scientific Recent Development
    Table 71. Agilent Technologies Company Details
    Table 72. Agilent Technologies Business Overview
    Table 73. Agilent Technologies Competent Cells Product
    Table 74. Agilent Technologies Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 75. Agilent Technologies Recent Development
    Table 76. Takara Bio Company Details
    Table 77. Takara Bio Business Overview
    Table 78. Takara Bio Competent Cells Product
    Table 79. Takara Bio Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 80. Takara Bio Recent Development
    Table 81. Promega Corporation Company Details
    Table 82. Promega Corporation Business Overview
    Table 83. Promega Corporation Competent Cells Product
    Table 84. Promega Corporation Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 85. Promega Corporation Recent Development
    Table 86. Beijing TransGen Biotech Company Details
    Table 87. Beijing TransGen Biotech Business Overview
    Table 88. Beijing TransGen Biotech Competent Cells Product
    Table 89. Beijing TransGen Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 90. Beijing TransGen Biotech Recent Development
    Table 91. GeneScript Corporation Company Details
    Table 92. GeneScript Corporation Business Overview
    Table 93. GeneScript Corporation Competent Cells Product
    Table 94. GeneScript Corporation Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 95. GeneScript Corporation Recent Development
    Table 96. Yeastern Biotech Company Details
    Table 97. Yeastern Biotech Business Overview
    Table 98. Yeastern Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 99. Yeastern Biotech Recent Development
    Table 100. New England Biolabs Company Details
    Table 101. New England Biolabs Business Overview
    Table 102. New England Biolabs Competent Cells Product
    Table 103. New England Biolabs Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 104. New England Biolabs Recent Development
    Table 105. QIAGEN N.V. Company Details
    Table 106. QIAGEN N.V. Business Overview
    Table 107. QIAGEN N.V. Competent Cells Product
    Table 108. QIAGEN N.V. Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 109. QIAGEN N.V. Recent Development
    Table 110. OriGene Technologies Company Details
    Table 111. OriGene Technologies Business Overview
    Table 112. OriGene Technologies Competent Cells Product
    Table 113. OriGene Technologies Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 114. OriGene Technologies Recent Development
    Table 115. Lucigen Company Details
    Table 116. Lucigen Business Overview
    Table 117. Lucigen Competent Cells Product
    Table 118. Lucigen Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 119. Lucigen Recent Development
    Table 120. Zymo Research Company Details
    Table 121. Zymo Research Business Overview
    Table 122. Zymo Research Competent Cells Product
    Table 123. Zymo Research Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 124. Zymo Research Recent Development
    Table 125. Bio-Rad Laboratories Company Details
    Table 126. Bio-Rad Laboratories Business Overview
    Table 127. Bio-Rad Laboratories Competent Cells Product
    Table 128. Bio-Rad Laboratories Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 129. Bio-Rad Laboratories Recent Development
    Table 130. Bioline Company Details
    Table 131. Bioline Business Overview
    Table 132. Bioline Competent Cells Product
    Table 133. Bioline Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 134. Bioline Recent Development
    Table 135. Delphi Genetics Company Details
    Table 136. Delphi Genetics Business Overview
    Table 137. Delphi Genetics Competent Cells Product
    Table 138. Delphi Genetics Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 139. Delphi Genetics Recent Development
    Table 140. IBA GmBH Company Details
    Table 141. IBA GmBH Business Overview
    Table 142. IBA GmBH Competent Cells Product
    Table 143. IBA GmBH Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 144. IBA GmBH Recent Development
    Table 145. Cell Applications Company Details
    Table 146. Cell Applications Business Overview
    Table 147. Cell Applications Competent Cells Product
    Table 148. Cell Applications Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 149. Cell Applications Recent Development
    Table 150. BioDynamics Laboratory Company Details
    Table 151. BioDynamics Laboratory Business Overview
    Table 152. BioDynamics Laboratory Competent Cells Product
    Table 153. BioDynamics Laboratory Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 154. BioDynamics Laboratory Recent Development
    Table 155. Scarab Genomics Company Details
    Table 156. Scarab Genomics Business Overview
    Table 157. Scarab Genomics Competent Cells Product
    Table 158. Scarab Genomics Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 159. Scarab Genomics Recent Development
    Table 160. GCC Biotech Company Details
    Table 161. GCC Biotech Business Overview
    Table 162. GCC Biotech Competent Cells Product
    Table 163. GCC Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 164. GCC Biotech Recent Development
    Table 165. SMOBIO Technology Company Details
    Table 166. SMOBIO Technology Business Overview
    Table 167. SMOBIO Technology Competent Cells Product
    Table 168. SMOBIO Technology Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 169. SMOBIO Technology Recent Development
    Table 170. Edge BioSystems Company Details
    Table 171. Edge BioSystems Business Overview
    Table 172. Edge BioSystems Competent Cells Product
    Table 173. Edge BioSystems Revenue in Competent Cells Business (2016-2021) & (US$ Million)
    Table 174. Edge BioSystems Recent Development
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Competent Cells Market Share by Type: 2020 VS 2027
    Figure 2. Chemically Competent Cells Features
    Figure 3. Electrocompetent Cells Features
    Figure 4. Global Competent Cells Market Share by Application: 2020 VS 2027
    Figure 5. Subcloning & Routine Cloning Case Studies
    Figure 6. Phage Display Library Construction Case Studies
    Figure 7. Toxic/Unstable DNA Cloning Case Studies
    Figure 8. High-Throughput Cloning Case Studies
    Figure 9. Protein Expression Case Studies
    Figure 10. Mutagenesis Case Studies
    Figure 11. Single-Stranded DNA Production Case Studies
    Figure 12. Bacmid Creation Case Studies
    Figure 13. Cre-Lox Recombination (PIR1/PIR2) Case Studies
    Figure 14. Competent Cells Report Years Considered
    Figure 15. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Competent Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Competent Cells Market Share by Regions: 2020 VS 2027
    Figure 18. Global Competent Cells Market Share by Regions (2022-2027)
    Figure 19. Global Competent Cells Market Share by Players in 2020
    Figure 20. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2020
    Figure 22. Global Competent Cells Revenue Market Share by Type (2016-2021)
    Figure 23. Global Competent Cells Revenue Market Share by Type (2022-2027)
    Figure 24. North America Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Competent Cells Market Share by Type (2016-2027)
    Figure 26. North America Competent Cells Market Share by Application (2016-2027)
    Figure 27. North America Competent Cells Market Share by Country (2016-2027)
    Figure 28. United States Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Competent Cells Market Share by Type (2016-2027)
    Figure 32. Europe Competent Cells Market Share by Application (2016-2027)
    Figure 33. Europe Competent Cells Market Share by Country (2016-2027)
    Figure 34. Germany Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Competent Cells Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Competent Cells Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Competent Cells Market Share by Region (2016-2027)
    Figure 44. China Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Competent Cells Market Share by Type (2016-2027)
    Figure 52. Latin America Competent Cells Market Share by Application (2016-2027)
    Figure 53. Latin America Competent Cells Market Share by Country (2016-2027)
    Figure 54. Mexico Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Competent Cells Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Competent Cells Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Competent Cells Market Share by Country (2016-2027)
    Figure 60. Turkey Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Merck KGaA Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 65. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 66. Takara Bio Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 67. Promega Corporation Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 68. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 69. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 70. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 71. New England Biolabs Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 72. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 73. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 74. Lucigen Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 75. Zymo Research Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 76. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 77. Bioline Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 78. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 79. IBA GmBH Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 80. Cell Applications Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 81. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 82. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 83. GCC Biotech Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 84. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 85. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2016-2021)
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Frequently Asked Questions
Competent Cells report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Competent Cells report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Competent Cells report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports